Langenfeld, Germany, June 03, 2026 (GLOBE NEWSWIRE) -- Booking Health today announced the release of findings examining international patient access to personalized dendritic cell therapy for glioblastoma in Germany. The findings, based on a documented Canadian patient case and supporting clinical research, highlight how cross-border treatment pathways may provide patients with aggressive brain tumors access to individualized immunotherapy options that are not widely available within all healthcare systems.
MUMBAI, India, June 3, 2026 /PRNewswire/ -- Renewal premiums contributed 55.09% of the total premium underwritten by India's life insurance industry in FY2024-25, reflecting...
Canadian and global investors gain early access to Opus One, a luxury residential development in IndiaMISSISSAUGA, ON, June 2, 2026 /CNW/ - Captain Advisory...
Belleza at Lakeview has two model homes opening soon for tours
MOUNTAIN HOUSE, Calif., Aug. 15, 2025 /PRNewswire/ -- Richmond American Homes of Maryland, Inc.,...
TUY HOA, Vietnam, Aug. 15, 2025 /PRNewswire/ -- Discover a tranquil retreat infused with modern luxuries at TUI BLUE Tuy Hoa, a wellness-focused resort hotel....
VANCOUVER, BC, Aug. 14, 2025 /PRNewswire/ - Nevada King Gold Corp. (TSXV: NKG) (OTCQB: NKGFF) ("Nevada King" or the "Company") is pleased to announce...